Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
6.9
55.49%
80%
—
73.58%
80%
—
5 Years
Score6.9
Net Growth55.49%
Net Trend80%
Net Income Consistency—
Rev Growth73.58%
Rev Trend80%
Revenue Consistency—
Sonoma Pharmaceuticals Inc fundamental performance
Between 2021 and 2026, revenue grew from $ 18M to $ 19M and net income went from -$ 3M to -$ 3M. Revenue increased in 4 of those 5 years; net income in 4.
Across Sonoma Pharmaceuticals Inc's full reported history, from 2007 to 2026, revenue grew from $ 4M to $ 19M and net income went from -$ 19M to -$ 3M. Revenue increased in 70% of the years measured; net income in 65%.
Sonoma Pharmaceuticals Inc currently holds a 5-year HDB Score of 6.9 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 1.37 | — |
1 Year2025-08-12 | $ 3.00 | -54.33% |
5 Years2021-08-12 | $ 115.40 | -98.81% |
10 Years2016-08-12 | $ 680.40 | -99.80% |
All Time2007-01-25 | $ 49.14K | -100.00% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2007-01-25 |
|---|---|---|---|---|---|
| Price | $ 1.37 | $ 3.00 | $ 115.40 | $ 680.40 | $ 49.14K |
| Return | — | -54.33% | -98.81% | -99.80% | -100.00% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2027 | $ 21M | -$ 2M | $ 5M |
| 2026 | $ 19M | -$ 3M | $ 2M |
| 2025 | $ 14M | -$ 3M | $ 5M |
| 2024 | $ 12M | -$ 4M | $ 3M |
| 2023 | $ 13M | -$ 5M | $ 3M |
| 2022 | $ 12M | -$ 5M | $ 7M |
| 2021 | $ 18M | -$ 3M | $ 4M |
| 2020 | $ 17M | -$ 3M | $ 3M |
| 2019 | $ 18M | -$ 11M | $ 3M |
| 2018 | $ 16M | -$ 14M | $ 10M |
| 2017 | $ 12M | $ 9M | $ 17M |
| 2016 | $ 9M | -$ 10M | $ 7M |
| 2015 | $ 13M | -$ 8M | $ 6M |
| 2014 | $ 13M | $ 3M | $ 5M |
| 2013 | $ 15M | -$ 5M | $ 7M |
| 2012 | $ 12M | -$ 7M | $ 3M |
| 2011 | $ 9M | -$ 7M | $ 4M |
| 2010 | $ 7M | -$ 8M | $ 6M |
| 2009 | $ 5M | -$ 17M | $ 1M |
| 2008 | $ 3M | -$ 20M | $ 18M |
| IPO2007 | $ 4M | -$ 19M | $ 19M |
Explore beyond SNOA
You're looking at Sonoma Pharmaceuticals Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
